(Q54564208)

1 June 2018

title

Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells. (English)

1 reference

1 June 2018

author name string

Yutaka Akiyama

1

1 reference

1 June 2018

Miyuki Nagai

2

1 reference

1 June 2018

Wataru Komaki

3

1 reference

1 June 2018

Kousuke Marutsuka

4

1 reference

1 June 2018

Yujiro Asada

5

1 reference

1 June 2018

Hiroaki Kataoka

6

1 reference

1 June 2018

publication date

1 August 2006

1 reference

1 June 2018

published in

Human Cell

1 reference

1 June 2018

volume

19

1 reference

1 June 2018

issue

3

1 reference

1 June 2018

page(s)

91-97

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1111/j.1749-0774.2006.00015.x

exact match

0 references

cites work

Scatter-factor and semaphorin receptors: cell signalling for invasive growth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Functional analysis of secreted and transmembrane proteins critical to mouse development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: identification of a distinct transcription start site for the HAI-2 gene in testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Gene expression profiling identifies matriptase overexpression in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2006.00015.X

Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis.

21 January 2018

1 reference

12 December 2020

Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas

1 reference

12 December 2020

Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1).

1 reference

12 December 2020

Activation of the zymogen of hepatocyte growth factor activator by thrombin

1 reference

12 December 2020

Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma

1 reference

12 December 2020

Role of cancer cell-stroma interaction in invasive growth of cancer cells

1 reference

12 December 2020

Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front

1 reference

12 December 2020

Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII

1 reference

12 December 2020

10.1111/J.1749-0774.2006.00015.X

Identifiers

DOI

1 reference

1 June 2018

Dimensions Publication ID

0 references

1 reference

1 June 2018